Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000624704 | SCV000740486 | pathogenic | not provided | 2017-03-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532819 | SCV003205149 | likely pathogenic | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-07-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr24276Leufs*5) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 520485). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150310 | SCV003837975 | likely pathogenic | Cardiomyopathy | 2022-02-11 | criteria provided, single submitter | clinical testing | |
Cardiogenetics and Myogenetics Molecular and Cellular Functional Unit, |
RCV004764934 | SCV005374978 | likely pathogenic | Dilated cardiomyopathy 1G | 2024-01-06 | no assertion criteria provided | clinical testing |